Blood Gas Analyzer Market Size & Share, by Product Type (i-Stat, ePOC, GEM Premier, ABL Flex, Cobas, RAPID Series), Modality (Portable, Bench-top), End Users (Hospital, Diagnostics Centers, Clinical Labs, Ambulatory Surgical Centers, Educational Institutes) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5645
  • Published Date: Feb 15, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Blood Gas Analyzer Market size is anticipated to reach USD 10 Billion by the end of 2036, growing at a CAGR of 5% during the forecast period i.e., 2024-2036. In the year 2023, the industry size of blood gas analyzers was over USD 2 Billion. The whole blood specimen's blood gas, pH, electrolyte, and certain metabolites are measured using blood gas analyzers. The main reasons propelling the market during this time are rapid urbanization, changing lifestyles, unhealthy eating habits, blood vessel bleeding, chronic illnesses, and technological improvements in the device. These analyzers are perfect for point-of-care testing and have several benefits for patients receiving critical care. For example, as of September 2021, 1,260,000 new and recurrent coronary attacks occur annually, according to the National Heart, Lung, and Blood Institute's Atherosclerotic Risk in Communities study and Cardiovascular Health Study; approximately 37% of individuals who experience a coronary attack in a given year pass away from it.

The global market for blood gas analyzers could see substantial growth if telemetry systems are integrated with blood gas analyzers. A growing trend in healthcare is remote patient monitoring, and using telemetry and blood gas analyzers together enables continuous patient monitoring from a distance. This can assist in resolving several enduring issues. Blood gas analyzers become much more useful when they can be integrated with telemetry; this opens up new clinical applications and paves the way for increased use of the devices in various care settings in the years to come. If companies in the blood gas analyzers market adjust to include these quickly developing connectivity capabilities, this offers them great growth prospects.


Blood Gas Analyzer Market
Get more information on this report: Request Free Sample PDF

Blood Gas Analyzer Sector: Growth Drivers and Challenges

Growth Drivers

  • Growing Advancement in Blood Gas Analyzer Technology - In comparison to earlier generations of machines, contemporary blood gas analyzers are more dependable, efficient, and user-friendly because of technological developments. Modern analyzer types have shorter turnaround times, take fewer blood or plasma samples, and yield more exact and reliable test findings. Platforms now contain sophisticated features like quality assurance, data management, and connection capabilities and are completely automated. More recent blood gas analyzers include advanced measurement methods, such as optical sensing, which get rid of problems like sensor drift and yield reliable values for the duration of the instrument. Real-time data sharing is made possible by bi-directional interfaces with laboratory information systems. Both the portability and user-friendliness of portable blood gas analyzers have increased. Blood gas testing now offers a far better value proposition because of these developments.
  • Miniaturization of Medical Devices - The market for blood gas analyzers has been significantly affected by the worldwide transition to the miniaturization of medical devices. The growing demand for miniaturized point-of-care testing equipment, such as blood gas analyzers, is due to devices getting smaller and portable. These compact analyzers allow blood gas analysis to be carried out at a patient's bedside or in any of the decentralized locations such as Intensive Care Units, Emergency rooms, ambulances, and doctor's offices. 

Challenges

  • High Cost of Equipment and Consumables – Blood gas analyzers are relatively expensive, and the cost of consumables, such as cartridges and electrodes can also be significant. This can be a barrier to adoption, especially in resource-limited settings.
  • Lack of data analysis software is set to hamper the market growth in the upcoming period. Reimbursement Issues are predicted to pose a limitation on the market growth in the forecast period.

Blood Gas Analyzer Market: Key Insights

Base Year

2023

Forecast Year

2024 - 2036

CAGR

~5%

Base Year Market Size (2023)

~USD 2 billion

Forecast Year Market Size (2036)

~USD 10 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Blood Gas Analyzer Segmentation

Modality (Portable, Bench-top)

Based on modality, the portable segment in the blood gas analyzer market is anticipated to hold the largest revenue share of 80% by the end of 2036. The portable gadgets have a higher adoption rate because they are simple to use, and manage, and need little upkeep. Numerous businesses are contributing to the creation and promotion of these goods. The segment is expanding due in part to an increase in product launches and partnerships. At MEDICA 2021, Boditech Med unveiled the AFIAS-10 immunoassay analyzer with a blood collection tube, which has an all-in-one cartridge system. A special integrated Sample-to-Answer system called the AFIAS-10 can run 10 tests in parallel for every parameter. Using automatic blood tube sample collection, AFIAS-10 offers a dependable test result with a fast and easy-to-use interface.

End Users (Hospitals, Diagnostics Centers, Clinical Labs, Ambulatory Surgical Centers, Educational Institutes, Others)

In terms of end-use, the clinical laboratory segment in the blood gas analyzer market is set to hold the highest CAGR by the end of the forecast period. In the forecast years, this segment of healthcare laboratories is expected to expand at a fast pace. Blood gas analyzers are typically larger, benchtop instruments that are capable of handling a higher volume of samples and performing a wider range of tests in clinical laboratories.

Our in-depth analysis of the global blood gas analyzer market includes the following segments:

          Product Type

  • i-Stat
  • ePOC
  • GEM Premier
  • ABL Flex
  •  Cobas
  • RAPID Series

          Modality

  • Portable
  • Bench-top

          End Users

  • Hospital
  • Diagnostics Centers
  • Clinical Labs
  •  Ambulatory Surgical Centers
  • Educational Institutes

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Blood Gas Analyzer Industry - Regional Synopsis

North American Market Forecasts

The blood gas analyzer market in the North American region is anticipated to grow at a revenue share of 80% by the end of 2036. In this region, the opportunities for companies in blood gas analyzers are projected to be very attractive due to increasing healthcare costs and the swift uptake of new technology. The importance of this market in the United States is driven by improved networks between multidisciplinary hospitals, insurance companies, and medical device manufacturers. For example, the United States Food and Drug Administration approved the Siemens Healthineers RAPIDPoint 500e Blood Gas Analyzer, used in critical care, in March 2020.

European Market Statistics

The blood gas analyzer market is estimated to hold a significant revenue share during the projected period. In particular, due to the increasing demand from larger, medium, and smaller hospitals in Europe's main countries for automated analyzers capable of fast multiparameter testing, Europe continues to grow. More diagnostics are being performed as a result of an increase in healthcare infrastructure and availability. The need for high throughput blood gas analyzers to efficiently manage workload is driven by this requirement. Up to 120 tests an hour can be performed with high precision by the majority of today's tools.

Research Nester
Blood Gas Analyzer Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Blood Gas Analyzer Landscape

top-features-companies
    • Radiometer Medical ApS
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Werfen
    • Nova Biomedical OPTI Medical Systems, Inc.
    • Accurex Biomedical Pvt. Ltd.
    • Medica Corporation
    • ERBA Diagnostics Inc.
    • F. Hoffmann-La Roche Ltd.
    • Sysmex America Inc
    • Bio-Rad Laboratories

In-the-news

In The News

  • Sysmex America Inc., a leading name in the diagnostics solutions market, received FDA approval for an additional feature to its N-10 automated hematology analyzer with blood bank mode in June 2022. For residual WBC counts, this is the first automated analyzer to be cleared.
  • Siemens Healthiness launched the Epoc Blood Analysis System in April 2021, a portable, wireless solution with complete blood gas, basic metabolic panel, and hematocrit and lactate on one room temperature stable test card that delivers patient side results within 1 minute. It will help to support efforts for COVID-19 response where blood gas testing plays a key role in treating infections.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5645
  • Published Date: Feb 15, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The growing prevalence of respiratory disease and advancement in blood gas analyzer technology are some of the major factors anticipated to drive the growth of the blood gas analyzer market.

The market is anticipated to attain a CAGR of ~5% over the forecast period, i.e., 2024-2036.

The major players in the market are Medica Corporation, ERBA Diagnostics Inc., F. Hoffmann-La Roche Ltd., Sysmex America Inc., Bio-Rad Laboratories, and others.

The portable segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in North America is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Blood Gas Analyzer Market Report Scope
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying